new version V2017

post stroke

     

TrialStudied treatmentControl treatmentpatientsROBResultNCT

anti hypertensive agents

telmisartan
PROFESS, 2008telmisartanplacebo -

anticoagulant

dicoumarol
Nat-Coop, 1962dicoumarolplaceboSuggesting
Howard, 1963dicoumarolplaceboNegative
phenindione
Thygesen, 1964phenindioneplaceboNegative
Enger, 1965phenindioneplaceboNegative
rivaroxaban
NAVIGATE ESUS, 2018rivaroxabanaspirin - NCT02313909
warfarin
SWAT, 1998warfarinaspirinNegative

antiplatelets drug

aspirin
AITA, 1975aspirinplaceboNegative
Reuther , 1976aspirinplaceboNegative
Canadian study (CCSG), 1978aspirinplaceboNegative
DCS, 1980aspirinplaceboNegative
AICLA, 1981aspirinplaceboNegative
Danish low-dose, 1986aspirinplaceboNegative
Swedish study , 1987aspirinplaceboNegative
UK-TIA low dose , 1988aspirinplaceboNegative
UK-TIA high dose , 1988aspirinplaceboSuggesting
SALT , 1991aspirinplaceboNegative
Lindblad , 1991aspirinplaceboSuggesting
ESPS 2 , 1996aspirinplaceboSuggesting
triflusal
TIM, 2000triflusalaspirin -

cholesterol lowering intervention

atorvastatin
SPARCL, 2006atorvastatinplacebopost stroke Low risk of bias SuggestingNCT00147602
simvastatin
HPS (post troke sub group), 2004simvastatinplacebopost stroke Exploratory Suggesting

prevention

folic acid
VITATOPS, 2010folic acid, vit B12 and vit B6placebo Low risk of bias SuggestingNCT00097669ÐX&